| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-05-05 | Soliris® (eculizumab) | prevention of acute antibody-mediated rejection (AMR) in sensitized deceased-donor kidney transplant recipients | 2 | Alexion Pharmaceuticals (USA - CT) | Transplantation |
| 2015-05-05 | Humira® (adalimumab) | non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis |
3 | Abbvie (USA - IL) | Ophtalmological diseases - Inflammatory diseases - Rare diseases |
| 2015-05-05 | clazakizumab (ALD518) | rheumatoid arthritis |
2b | Alder Biopharmaceuticals (USA - WA) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2015-05-05 | MM-141 (istiratumab) | metastatic pancreatic cancer |
2 | Merrimack Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2015-05-05 | Col-Treg | autoimmune uveitis | preclinical | TxCell (France) | Autoimmune diseases - Inflammatory diseases - Ophtalmological diseases - Rare diseases |
| 2015-05-05 | human Retinal Progenitor Cell (hRPC) therapy | retinitis pigmentosa | 1-2 | Reneuron (UK) | Genetic diseases - Ophtalmological diseases - Rare diseases |
| 2015-05-04 | OpRegen® | preclinical | BioTime (USA - CA) Cell Cure Neurosciences (Israel) | Ophtalmological diseases | |
| 2015-05-03 | NuQ® assays | prostate cancer |
VolitionRx (Singapore) ImmuneHealth (Belgium) | Diagnostic - Cancer - Oncology | |
| 2015-04-30 | RE-024 (fosmetpantotenate) | pantothenate kinase-associated neurodegeneration (PKAN) | 1 | Retrophin (USA - CA) | Rare diseases - Neurodegenerative diseases - Genetic diseases |
| 2015-04-29 | AG-881 | 1 | Agios Therapeutics (USA - MA) Celgene (USA - NJ) | Cancer - Oncology | |
| 2015-04-29 | APD371 | pain, fibrotic diseases |
1 | Arena Pharmaceuticals (USA - CA) | CNS diseases - Fibrotic diseases |
| 2015-04-29 | X-82 | wet age-related macular degeneration (AMD) |
2 | Tyrogenex (USA - Fl) | Ophtalmological diseases |
| 2015-04-29 | monitoring of biotherapies with LISA TRACKER combined to CRP dosing | inflammatory bowel disease |
Theradiag (France) | Inflammatory diseases - Gastrointestinal diseases | |
| 2015-04-28 | Liletta™ (levonorgestrel-releasing intrauterine system) | contraception |
3 | Actavis (Ireland) Medicines360 (USA - CA) | Women health |
| 2015-04-28 | RIPK2 drug discovery program | Oncodesign (France) | Autoimmune diseases | ||
| 2015-04-28 | Synthon GTR (glatiramer acetate) | relapsing remitting multiple sclerosis |
3 | Synthon (The Netherlands) | Neurodegenerative diseases |
| 2015-04-28 | TransCon Treprostinil | pulmonary arterial hypertension (PAH) |
1 | Ascendis Pharma (Denmark) | Rare diseases - Cardiovascular diseases |
| 2015-04-28 | PTC596 - oncology program targeting BMI1 | advanced solid tumors |
PTC Therapeutics (USA - NJ) | Cancer - Oncology | |
| 2015-04-28 | herpes zoster vaccine (HZ/su) containing Agenus\' QS-21 Stimulon®1 adjuvant | shingles |
3 | GSK (UK) Agenus (USA - MA) | Infectious diseases |
| 2015-04-27 | ofatumumab (Arzerra™) | relapsed chronic lymphocytic leukemia (CLL) | 3 | Novartis (Switzerland) | Cancer - Oncology |
